STOCK TITAN

Cloud Dx Stock Price, News & Analysis

CDXFF OTC

Company Description

Cloud DX Inc. (OTCQB: CDXFF), historically associated with the surgical and medical instrument manufacturing industry, operated as a digital health company focused on virtual care and remote patient monitoring. According to multiple company news releases, Cloud DX developed and deployed the Connected Health™ remote patient monitoring platform, which was used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable aging in place, and deliver hospital-quality post-surgical care in the home.

The company stated that its partners used Connected Health to help patients manage chronic conditions, reduce the need for hospitalization or re-admission, and lower healthcare delivery costs through more efficient use of resources. Cloud DX described itself as a North American provider of virtual care and remote patient monitoring platforms, with contracts and relationships that included hospitals, community paramedic services, clinics, and provincial or territorial health authorities.

Cloud DX highlighted that its Connected Health platform supported programs where community paramedics and other care teams could monitor seniors and other patients where they live, track vital signs and symptoms, and interact with patients through a mobile app. The company indicated that this approach was used to help people remain at home longer, manage chronic diseases, and support post-surgical recovery outside of hospital settings.

In its public communications, Cloud DX reported that it had secured multiple provincial-level contracts for remote patient monitoring services in Canada, as well as agreements with hospitals, academic medical centers, family health teams, community paramedic services, and clinics. It also referenced a Master Services Agreement with a shared services organization that manages procurement for hospital systems and provincial authorities. These disclosures positioned Cloud DX as a supplier of remote patient monitoring products and services to a range of institutional healthcare customers.

The company also emphasized recognition it had received, noting that Cloud DX was the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist, and identified as one of "Canada's Ten Most Prominent Telehealth Providers." In various releases, Cloud DX further noted that it had been named a "2022 Top Innovator" by Canadian Business.

Cloud DX’s public statements described an overarching mission of "accelerating digital healthcare" and a goal to make healthcare better for everyone. The Connected Health platform was presented as a way for healthcare organizations to deliver virtual care, manage complex patients remotely, and use resources more efficiently while aiming for improved patient and provider outcomes.

Corporate restructuring and cessation of operations

Subsequent disclosures show that Cloud DX underwent a significant restructuring process. On June 6, 2024, the company announced that its wholly owned subsidiary, Cloud Diagnostics Canada ULC, had filed a Notice of Intention to Make a Proposal under the Bankruptcy and Insolvency Act (Canada). Cloud Diagnostics Canada ULC was described as a material subsidiary that accounted for most of the company’s revenues. The NOI filing initiated a court-supervised process intended to allow a restructuring of the subsidiary’s affairs and to support a sale and investment solicitation process.

On December 16, 2024, Cloud DX reported the sale of its wholly owned subsidiary Cloud Diagnostics Canada ULC to 1493907 B.C. Ltd. under a reverse vesting order granted by the Supreme Court of British Columbia. As part of this transaction, existing shares in Cloud Diagnostics Canada ULC were cancelled, new shares were issued to the purchaser, and a new entity was incorporated and vested with certain excluded liabilities, with that new entity expected to be assigned into bankruptcy under the Bankruptcy and Insolvency Act.

On June 11, 2025, Cloud DX disclosed that it had received a Cease Trade Order from the Ontario Securities Commission on May 7, 2025, due to its inability to file audited financial statements for the 2024 fiscal year. The same release stated that trading of the company’s shares had initially been halted when a subsidiary filed the NOI in June 2024 and that, following completion of the reverse vesting transaction on December 13, 2024, the company ceased operations and all assets of the company were transferred to the purchaser. The news release further noted that on May 27, 2025, the company’s board of directors was dissolved.

Based on these public disclosures, Cloud DX Inc. is best understood in historical terms. The CDXFF symbol is associated with a company that formerly operated a remote patient monitoring and virtual care platform, but which reported that it had ceased operations and transferred its assets following a court-supervised transaction. Investors researching CDXFF should treat this as a former operating company with a restructuring and asset transfer history, rather than an ongoing growth-stage issuer.

Business focus before cessation of operations

Before the restructuring and cessation of operations, Cloud DX’s stated business focus centered on:

  • Remote patient monitoring (RPM): Providing the Connected Health remote patient monitoring platform to healthcare enterprises and care teams across North America.
  • Virtual care delivery: Enabling chronic disease management, aging in place, and post-surgical care at home through connected monitoring and communication tools.
  • Institutional healthcare contracts: Supplying RPM products and services under contracts with hospitals, community paramedic services, clinics, and provincial or territorial health authorities, as described in the company’s news releases.

These activities framed Cloud DX as a digital health and remote monitoring provider within the broader manufacturing and medical technology ecosystem, with its stock traded on the TSX Venture Exchange under the symbol CDX and on the OTCQB under the symbol CDXFF during its operating period.

FAQs about Cloud DX Inc. (CDXFF)

  • Q: What did Cloud DX Inc. do?
    A: Cloud DX Inc. described itself as a North American digital health platform and provider of virtual care and remote patient monitoring solutions. Its Connected Health remote patient monitoring platform was used by healthcare enterprises and care teams to manage chronic disease, support aging in place, and deliver hospital-quality post-surgical care in the home.
  • Q: What is the Connected Health remote patient monitoring platform?
    A: In the company’s public statements, Connected Health was presented as a remote patient monitoring platform that allowed healthcare organizations and care teams to monitor patients virtually. It was used to track chronic conditions, support seniors and other patients at home, and provide post-surgical monitoring outside of hospital settings.
  • Q: Who were Cloud DX’s typical customers?
    A: Company news releases state that Cloud DX supplied remote patient monitoring products and services to healthcare enterprises and care teams across North America, including hospitals, community paramedic services, clinics, and provincial or territorial health authorities under various contracts and agreements.
  • Q: What recognition and awards did Cloud DX report?
    A: Cloud DX reported that it was the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist, and one of "Canada's Ten Most Prominent Telehealth Providers." It also noted recognition as a "2022 Top Innovator" by Canadian Business.
  • Q: What restructuring steps did Cloud DX disclose?
    A: On June 6, 2024, Cloud DX announced that its wholly owned subsidiary Cloud Diagnostics Canada ULC had filed a Notice of Intention to Make a Proposal under the Bankruptcy and Insolvency Act (Canada). On December 16, 2024, the company reported the sale of that subsidiary to 1493907 B.C. Ltd. under a reverse vesting order granted by the Supreme Court of British Columbia.
  • Q: Did Cloud DX cease operations?
    A: In a June 11, 2025 news release, Cloud DX stated that, with the closing of the reverse vesting transaction on December 13, 2024, the company ceased operations and all assets of the company were transferred to the purchaser. The same release noted that the company’s board of directors was dissolved on May 27, 2025.
  • Q: What happened to trading in Cloud DX’s shares?
    A: The June 11, 2025 news release reported that the Ontario Securities Commission issued a Cease Trade Order on May 7, 2025 because the company was unable to file audited financial statements for the 2024 fiscal year. The company also noted that trading of its shares had initially been halted when a subsidiary filed a Notice of Intention to Make a Proposal in June 2024.
  • Q: Is Cloud DX still an operating company?
    A: Based on the company’s own disclosures, Cloud DX reported that it ceased operations upon closing of the reverse vesting transaction in December 2024 and transferred all assets to the purchaser. Its later communication focused on the cease trade order and dissolution of its board, indicating that CDXFF is best viewed as a former operating issuer.

Stock Performance

$—
0.00%
0.00
Last updated:
+8.95%
Performance 1 year

SEC Filings

No SEC filings available for Cloud Dx.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Cloud Dx (CDXFF)?

The current stock price of Cloud Dx (CDXFF) is $0.084 as of February 7, 2025.

What business was Cloud DX Inc. (CDXFF) involved in?

Cloud DX Inc. described itself as a North American digital health platform and provider of virtual care and remote patient monitoring solutions. Its Connected Health remote patient monitoring platform was used by healthcare enterprises and care teams across North America to manage chronic disease, enable aging in place, and deliver hospital-quality post-surgical care in the home.

What is the Connected Health remote patient monitoring platform from Cloud DX?

According to the company’s news releases, the Connected Health remote patient monitoring platform allowed healthcare enterprises and care teams to virtually manage chronic disease, support aging in place, and provide hospital-quality post-surgical care in the home. Partners used the platform to improve healthcare and patient outcomes, reduce the need for hospitalization or re-admission, and lower healthcare delivery costs through more efficient use of resources.

Who used Cloud DX’s products and services?

Cloud DX stated that its Connected Health remote patient monitoring platform was used by healthcare enterprises and care teams across North America. Its contracts and agreements included hospitals, community paramedic services, clinics, and provincial or territorial health authorities, as described in the company’s public announcements.

What awards and recognition did Cloud DX report receiving?

Cloud DX reported that it was the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist, and one of "Canada's Ten Most Prominent Telehealth Providers." The company also stated that it was named a "2022 Top Innovator" by Canadian Business.

What restructuring process did Cloud DX undertake?

On June 6, 2024, Cloud DX announced that its wholly owned subsidiary, Cloud Diagnostics Canada ULC, filed a Notice of Intention to Make a Proposal under the Bankruptcy and Insolvency Act (Canada). The company explained that this filing initiated a formal process, including a sale and investment solicitation process, to explore a sale or investment in the subsidiary’s business or assets under court supervision.

What happened in the sale of Cloud Diagnostics Canada ULC?

On December 16, 2024, Cloud DX reported that its wholly owned subsidiary Cloud Diagnostics Canada ULC was sold to 1493907 B.C. Ltd. The transaction was completed under a reverse vesting order granted by the Supreme Court of British Columbia. Existing shares in Cloud Diagnostics Canada ULC were cancelled, new shares were issued to the purchaser, and a new entity was incorporated and vested with certain excluded liabilities that was expected to be assigned into bankruptcy.

Did Cloud DX cease operations?

In a June 11, 2025 news release, Cloud DX stated that with the closing of the reverse vesting transaction on December 13, 2024, the company ceased operations and all assets of the company were transferred to the purchaser. The same release reported that the company’s board of directors was dissolved on May 27, 2025.

Why was a Cease Trade Order issued against Cloud DX?

Cloud DX disclosed that the Ontario Securities Commission issued a Cease Trade Order on May 7, 2025 because the company was unable to file audited financial statements for its 2024 fiscal year. The company also noted that trading of its shares had previously been halted when a subsidiary filed a Notice of Intention to Make a Proposal in June 2024.

Does Cloud DX Inc. still operate its remote patient monitoring business?

Based on the company’s own disclosures, Cloud DX reported that it ceased operations when the reverse vesting transaction closed on December 13, 2024 and that all assets were transferred to the purchaser. This indicates that the remote patient monitoring business previously associated with Cloud DX is no longer operated by the company under the CDXFF symbol.

How should investors view the CDXFF ticker now?

Given the company’s statements about ceasing operations, transferring all assets to a purchaser, and receiving a Cease Trade Order, CDXFF represents a former operating issuer with a restructuring and asset transfer history. Anyone researching CDXFF is reviewing the historical record of Cloud DX Inc. rather than an active growth-stage operating company.